UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

L’invalidation de la voie Wnt/b-catenin in vitro et in vivo dans des cellules tumorales cortico-surrénaliennes inhibe la prolifération et augmente l’apoptose cellulaire

Annales d'endocrinologie, 2012-09, Vol.73 (4), p.265-265

2012

Volltextzugriff (PDF)

Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment

Journal of endocrinological investigation, 2023-07, Vol.46 (7), p.1449-1458

2023

Volltextzugriff (PDF)

Genetic characterization of a mouse line with primary aldosteronism

Journal of molecular endocrinology, 2017-02, Vol.58 (2), p.67-78

2017

Volltextzugriff (PDF)

Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma

Oncogenesis (New York, NY), 2015-07, Vol.4 (7), p.e161-e161

2015

Volltextzugriff (PDF)

A role for vault particles as mediator for therapeutic effects against endocrine tumors

Experimental and clinical endocrinology & diabetes, 2015, Vol.122 (3)

2015

Volltextzugriff (PDF)

Evaluation of a standardized protocol for processing adrenal tumor samples: preparation for a European adrenal tumor bank

Hormone and metabolic research, 2010-02, Vol.42 (2), p.93-101

2010

Volltextzugriff (PDF)

P02-40 Anti-IGF1 receptor immunoliposomes: A single formulation combining two anticancer treatments with enhanced therapeutic efficiency

Growth hormone & IGF research, 2012-10, Vol.22, p.S57-S57

2012

Volltextzugriff (PDF)

12407 Assessing Human Monocyte Migration And Co-culture With Adrenocortical Cancer Cells

Journal of the Endocrine Society, 2024-10, Vol.8 (Supplement_1)

2024

Volltextzugriff (PDF)

12407 Assessing Human Monocyte Migration And Co-culture With Adrenocortical Cancer Cells

Journal of the Endocrine Society, 2024-10, Vol.8 (Supplement_1)

2024

Volltextzugriff (PDF)

36P Progesterone and trabectedin activity in preclinical cell models of adrenocortical carcinoma

ESMO open, 2024-03, Vol.9, p.102425, Article 102425

2024

Volltextzugriff (PDF)

Repeated immunoliposomal treatment of endocrine tumors

Experimental and clinical endocrinology & diabetes, 2015, Vol.122 (3)

2015

Volltextzugriff (PDF)

Repeated immunoliposomal treatment of endocrine tumors

Experimental and clinical endocrinology & diabetes, 2015, Vol.122 (3)

2015

Volltextzugriff (PDF)

Investigation of a novel liposomal chemotherapy protocol in three preclinical models for adrenocortical carcinoma in vivo

Experimental and clinical endocrinology & diabetes, 2015, Vol.122 (3)

2015

Volltextzugriff (PDF)

8526 The WEE1 Kinase Inhibitor Adavosertib - A Promising Therapeutic Enhancer Of Cytotoxic Therapies In Advanced Adrenocortical Carcinoma

Journal of the Endocrine Society, 2024-10, Vol.8 (Supplement_1)

2024

Volltextzugriff (PDF)

Investigation of novel chemotherapeutic combinations in a tumor model of adrenocortical carcinoma

Experimental and clinical endocrinology & diabetes, 2013, Vol.121 (3)

2013

Volltextzugriff (PDF)

MUC-1 – a novel preclinical model for adrenocortical carcinoma?

Experimental and clinical endocrinology & diabetes, 2014, Vol.122 (3)

2014

Volltextzugriff (PDF)

Differential TNFα and Toll-like-receptor 4-signaling in endocrine tumors after tumor-vascular-disrupting agent ASA404 (vadimezan) and TNFα treatment

Experimental and clinical endocrinology & diabetes, 2014, Vol.122 (3)

2014

Volltextzugriff (PDF)

Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of [beta]-catenin in adrenocortical carcinoma

Oncogenesis (New York, NY), 2015-07, Vol.4, p.e161

2015

Volltextzugriff (PDF)

Ocean Heat Transport Across 24°N Latitude

Interactions Between Global Climate Subsystems, 1993, p.65-75

1993

Volltextzugriff (PDF)

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial

Journal of thrombosis and haemostasis, 2007-11, Vol.5 (11), p.2178-2185

2007

Volltextzugriff (PDF)

SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials

Diabetes & vascular disease research, 2015-03, Vol.12 (2), p.90-100

2015

Volltextzugriff (PDF)

Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2013-03, Vol.31 (7), p.961-965

2013

Volltextzugriff (PDF)

Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II). A randomised, double-blind, non-inferiority trial

Thrombosis and haemostasis, 2011-04, Vol.105 (4), p.721-729

2011

Volltextzugriff (PDF)

Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer

Thrombosis and haemostasis, 2015, Vol.114 (1), p.150-157

2015

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(5)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

L’invalidation de la voie Wnt/b-catenin in vitro et in vivo dans des cellules tumorales cortico-surrénaliennes inhibe la prolifération et augmente l’apoptose cellulaire

Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment

Genetic characterization of a mouse line with primary aldosteronism

Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma

A role for vault particles as mediator for therapeutic effects against endocrine tumors

Evaluation of a standardized protocol for processing adrenal tumor samples: preparation for a European adrenal tumor bank

P02-40 Anti-IGF1 receptor immunoliposomes: A single formulation combining two anticancer treatments with enhanced therapeutic efficiency

12407 Assessing Human Monocyte Migration And Co-culture With Adrenocortical Cancer Cells

12407 Assessing Human Monocyte Migration And Co-culture With Adrenocortical Cancer Cells

36P Progesterone and trabectedin activity in preclinical cell models of adrenocortical carcinoma

Repeated immunoliposomal treatment of endocrine tumors

Repeated immunoliposomal treatment of endocrine tumors

Investigation of a novel liposomal chemotherapy protocol in three preclinical models for adrenocortical carcinoma in vivo

8526 The WEE1 Kinase Inhibitor Adavosertib - A Promising Therapeutic Enhancer Of Cytotoxic Therapies In Advanced Adrenocortical Carcinoma

Investigation of novel chemotherapeutic combinations in a tumor model of adrenocortical carcinoma

MUC-1 – a novel preclinical model for adrenocortical carcinoma?

Differential TNFα and Toll-like-receptor 4-signaling in endocrine tumors after tumor-vascular-disrupting agent ASA404 (vadimezan) and TNFα treatment

Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of [beta]-catenin in adrenocortical carcinoma

Ocean Heat Transport Across 24°N Latitude

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial

SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials

Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update

Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II). A randomised, double-blind, non-inferiority trial

Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer

Suchergebnisse filtern